February 2020
Washington, D.C. (Feb. 6, 2020)—Today, Rep. Harley Rouda, the Chairman of the Subcommittee on Environment, and Rep. Rashida Tlaib, the Vice Chairwoman of the Subcommittee, sent a letter asking the Environmental Protection Agency to investigate the chemical release incident at the Detroit facility of the Marathon Petroleum Corporation on September 12, 2019.
Washington, D.C. (Feb. 5, 2020)—Today, Rep. Raja Krishnamoorthi, the Chairman of the Subcommittee on Economic and Consumer Policy, released a staff memo detailing new information uncovered in the Subcommittee's investigation of the youth vaping epidemic.
Washington, D.C. (Feb. 5, 2020)—Today, Rep. Carolyn B. Maloney, the Chairwoman of the Committee on Oversight and Reform, issued the following statement on the House floor in support of S.394, the Presidential Transition Enhancement Act, a bill to strengthen the ethics requirements for presidential transition team members.
Washington, D.C. (Feb. 4, 2020)—Rep. Carolyn B. Maloney, the Chairwoman of the Committee on Oversight and Reform, and Senator Elizabeth Warren, a member of the Senate Committee on Health, Education, Labor and Pensions, sent a letter asking the Government Accountability Office (GAO) to examine the total annual medical costs associated with gun violence in the United States.
Washington, D.C. (Feb. 3, 2020)—Today, Rep. Carolyn B. Maloney, the Chairwoman of the Committee on Oversight and Reform, announced that James Carroll, the Director of the Office of the National Drug Control Policy (ONDCP), has agreed to testify at a hearing on February 27, 2020. The hearing will examine the recently released 2020 National Drug Control Strategy and the Administration's response to the ongoing drug epidemic.
Chairwoman Maloney issued a statement following the release of the 2020 National Drug Control Strategy today:
Washington, D.C. (Feb. 3, 2020)—Today, Rep. Carolyn B. Maloney, the Chairwoman of the Committee on Oversight and Reform, sent a letter warning Secretary of Education Betsy DeVos that the Committee may issue a subpoena to compel her testimony following her refusal to appear at a public hearing and instead attend campaign events in Iowa and Pennsylvania this week on behalf of President Trump.